09/01/2026
📢 A Message from Our CEO
Our latest Shareholder Letter is now live!
Read the full update from Daxor’s CEO and President Michael Feldschuh where he shares key highlights on our clinical momentum, commercial progress, and strategic vision for advancing precision blood volume analysis.
Read the letter here: https://daxor.com/daxor-corporation-ceo-and-president-michael-feldschuh-delivers-1st-half-corporate-update-in-shareholder-letter-2/